C.O. Blanco et al.
Inorganica Chimica Acta 524 (2021) 120429
(CH3); 19.75 (2CH3); 20.45 (CH3); 20.46 (CH3); 27.43 (2CH2); 33.79
(2CH2); 47.99 (CH); 48.02 (CH); 53.60 (C); 53.69 (C); 63.31 (C); 63.41
(C); 124.71 (2CH); 125.92 (2CH); 127.47 (C); 128.64 (CH); 129.01
(CH); 129.60 (CH); 131.75 (4CH); 139.11 (2C); 139.68 (2C); 154.74
(2C). Elemental analysis for C34H37N4Br: Calculated: C, 70.22%; H,
6.41%; N, 9.63%. Found: C, 70.10%; H 6.40%; N, 9.32%.
(C); 160.52 (C); 161.13 (C). Elemental analysis for C44H52ClN4PF6Ru:
Calculated: C, 57.54%; H, 5.71%; N, 6.10%; F, 12.41%. Found: C,
57.16%; H, 5.58%; N 6.14%; F, 12.41%.
Complex 3: [(p-cymene)RuCl2] (100 mg, 163
μ
mol) in dichloro-
mol) in dichloromethane
(5.0 mL). Ammonium hexafluorophosphate (164 mg, 4.12 mmol). Or-
ange solid product (140 mg, 80%). M.P.: 192–195 ◦C (d). IR (KBr) (
methane (5.0 mL) and ligand L3 (217 mg, 326
μ
ν
,
cmꢀ 1): 3050 (w), 2958 (m), 2875 (w), 1625 (w), 1597 (w), 1534 (w),
1507 (w), 1454 (m), 1438 (m), 1398 (m), 1134 (m), 854 (s), 741 (m), 705
(m), 557 (s). 1H NMR (300 MHz, CDCl3) (δ, ppm): 0.60 (s, 3H, CH3); 0.74
(s, 6H, iPr-2CH3); 0.88 (s, 3H, CH3); 0.93 (s, 3H, CH3); 0.97 (s, 3H, CH3);
1.01 (s, 3H, CH3); 1.13 (s, 3H, CH3); 1.61 (s, 3H, cymene-CH3);
1.69–1.86 (m, 4H, 2CH2); 1.91–2.17 (m, 4H, 2CH2); 2.20–2.37 (m, 1H,
iPr-CH); 2.93–2.94 (d, J = 3.7 Hz, 1H, CH); 3.04–3.05 (d, J = 3.7 Hz, 1H,
CH); 3.78–4.05 (s, 2H, cymene-2CH); 4.80–5.02 (d, 2H, cymene-2CH);
7.79 (m, 8H, 8CH). 13C{1H} NMR (75 MHz, CDCl3) (δ, ppm): 12.05
(CH3); 12.56 (CH3); 19.07 (CH3); 19.34 (CH3); 19.81 (CH3); 20.18
(CH3); 20.30 (CH3); 21.62 (CH3); 21.80 (CH3); 26.64 (CH2); 27.31
(CH2); 31.16 (CH); 33.23 (CH2); 33.53 (CH2); 47.83 (CH); 48.07 (CH);
54.55 (C); 55.25 (C); 62.47 (C); 65.19 (C); 78.42 (2CH); 84.47 (2CH);
101.50 (C); 104.97 (C); 124.94 (C); 125.84 (C); 125.10 (4CH); 126.81
(CH); 127.01 (CH); 132.83 (4CH); 136.23 (2C); 138.13 (C); 139.08 (C);
160.96 (C); 161.54 (C). Elemental analysis for C44H50Br2ClN4RuPF6:
Calculated: C, 49.11%; H, 4.68%; N, 5.21%. Found: C, 49.34%; H,
4.79%; N, 5.17%.
2.3. General procedure to the synthesis of ruthenium complexes
The ligand was dissolved in dichloromethane or chloroform, and
slowly added to a solution of the precursor [(p-cymene)RuCl2] dissolved
in the same solvent. The solution was stirred for 24 h at room temper-
ature. The formed suspension was filtered to separate a solid identified
as impurities. The resulting solution was rotavaporated, obtaining a
solid that was dried under vacuum. This solid was dissolved in ethanol
and ammonium hexafluorophosphate was added and stirred at room
temperature. After 24 h of stirring, the solution was rotavaporated
obtaining a solid which was dried under vacuum. This solid was dis-
solved in chloroform and filtered using a Pasteur pipette with silica gel.
The resulting solution was rotavaporated to obtain a solid as the final
product. The recrystallization of the complexes was carried out in an
ethanol-hexane mixture. The mixture was cooled to ꢀ 5 ◦C during an
appropriate period, obtaining crystalline solids which were dried under
vacuum.
Complex 1: [(p-cymene)RuCl2] (100 mg, 163
μmol) in chloroform
Complex 4: [(p-cymene)RuCl2] (100 mg, 163
μ
mol) in dichloro-
(5.0 mL), ligand L1 (114 mg, 326 mol) in chloroform (5.0 mL).
μ
methane (5.0 mL) and ligand L4 (141 mg, 331
μmol) in dichloromethane
Ammonium hexafluorophosphate (181 mg, 1.11 mmol). Orange solid
product (146 mg, 70%). M.P.: 190–194 ◦C (d). IR (KBr) (
ν
, cmꢀ 1): 3264
(5.0 mL). Ammonium hexafluorophosphate (227 mg, 1.39 mmol). Or-
ange solid product (152 mg, 66%). Reddish orange crystals were ob-
(s), 2964 (s), 2877 (w), 1554 (w), 1538 (w), 1472 (m), 1438 (m), 1392
(m), 1285 (m), 1135 (w), 848 (s), 558 (s). 1H NMR (300 MHz, CDCl3) (δ,
ppm): 0.62 (s, 3H, CH3); 0.71 (s, 3H, CH3); 0.85–0.86 (d, J = 7.0 Hz, 3H,
iPr-CH3); 0.87–0.89 (d, J = 6.8 Hz, 3H, iPr-CH3); 0.91 (s, 3H, CH3); 0.93
(s, 3H, CH3), 1.05–1.12 (m, 2H, CH2); 1.18–1.34 (m, 2H, CH2); 1.37 (s,
3H, CH3); 1.39 (s, 3H, CH3); 1.81–1.93 (m, 2H, CH2); 2.04–2.16 (m, 2H,
CH2); 2.20 (s, 3H, cymene-CH3); 2.35–2.41 (m, 1H, iPr-CH); 2.86–2.87
(d, J = 3.7 Hz, 1H, CH); 2.88–2.89 (d, J = 3.7 Hz, 1H, CH); 5.74–5.82
(dd, J = 5.9 Hz, 2H, cymene 2CH); 6.04–6.13 (dd, J = 5.9 Hz, 2H,
cymene 2CH); 12.01 (s, 1H, NH); 12.18 (s, 1H, NH). 13C{1H} NMR (75
MHz, CDCl3) (δ, ppm): 10.23 (CH3); 10.48 (CH3); 19.19 (CH3); 19.26
(CH3); 19.39 (CH3); 20.07 (CH3); 20.37 (CH3); 21.81 (CH3); 21.83
(CH3); 26.83 (CH2); 27.38 (CH2); 31.06 (CH); 33.19 (CH2); 33.25 (CH2);
47.89 (2CH); 53.42 (C); 53.45 (C); 63.39 (C); 63.66 (C); 79.35 (CH);
79.59 (CH); 83.80 (CH); 83.99 (CH); 101.06 (C); 105.10 (C); 124.45 (C);
124.91 (C); 137.76 (C); 137.81 (C); 161.37 (C); 161.44 (C). Elemental
analysis for C32H44ClN4PF6Ru⋅1.2H2O: Calculated: C, 48.79%; H,
5.94%; N, 7.11%; F, 14.47%. Found: C, 48.41%; H, 5.66%; N, 7.01%: F,
14.88%.
tained (84 mg, 36%). M.P.: 256–260 ◦C (d). IR (KBr) (
ν
, cmꢀ 1): 3356 (m),
3056 (w), 2962 (m), 2926 (m), 2874 (w), 1624 (w), 1534 (w), 1506 (m),
1455 (m), 1435 (m), 1391 (m), 1275 (m), 1133 (m), 841 (s), 737 (w), 701
(m), 557 (s). 1H NMR (300 MHz, CDCl3) (δ, ppm): 0.64–2.31 (m, 72H,
18CH3, 18CH); 2.86–3.02 (m, 4H, 4CH); 4.14 (s, 2H, cymene 2CH); 4.81
(s, 2H, cymene 2CH); 5.45 (s, 2H, cymene 2CH); 5.87 (s, 2H, cymene
2CH); 7.65–7.73 (m, 10H, 10CH); 11.47 (s, 1H, NH); 11.54 (s, 1H, NH).
13C{1H} NMR (75 MHz, CDCl3) (δ, ppm): Isomer A: 9.85 (CH3); 10.29
(CH3); 19.09 (CH3); 19.24 (CH3); 20.16 (CH3); 20.26 (CH3); 21.53
(CH3); 22.00 (2CH3); 26.63 (CH2); 27.40 (CH2); 31.05 (CH); 32.96
(CH2); 33.55 (CH2); 47.71 (CH); 48.07 (CH); 53.76 (C); 53.80 (C); 62.51
(C); 63.74 (C); 78.15 (CH); 78.86 (CH); 82.87 (CH); 84.84 (CH); 97.19
(C); 104.50 (C); 125.72 (C); 125.93 (C); 129.61 (2CH); 130.90 (2CH);
131.08 (CH); 137.68 (C); 137.72 (C); 139.03 (C); 160.23 (C); 161.74 (C).
Isomer B: 10.28 (CH3); 11.87 (CH3); 19.20 (CH3); 19.27 (CH3); 20.31
(CH3); 20.40 (CH3); 21.75 (CH3); 22.07 (2CH3); 26.87 (CH2); 27.44
(CH2); 31.10 (CH); 33.21 (CH2); 33.73 (CH2); 47.97 (CH); 48.07 (CH);
54.27 (C); 54.92 (C); 63.63 (C); 64.79 (C); 79.43 (CH); 79.76 (CH);
82.98 (CH); 84.98 (CH); 101.78 (C); 105.10 (C); 125.08 (C); 125.75 (C);
129.61 (2CH); 130.90 (2CH); 131.08 (CH); 137.68 (C); 137.47 (C);
138.58 (C), 160.98 (C); 161.93 (C). Elemental analysis for
Complex 2: [(p-cymene)RuCl2] (274 mg, 448
methane (5.0 mL), ligand L2 (450 mg, 895 mol) in dichloromethane
(5.0 mL). Ammonium hexafluorophosphate (722 mg, 4.42 mmol). Or-
ange solid product (802 mg, 98%). M.P.: 242–244 ◦C (d). IR (KBr) (
μmol) in dichloro-
μ
C
38H48ClN4PF6Ru⋅0.4H2O: Calculated: C, 53.73%; H, 5.79%; N, 6.60%;
F, 13.42%. Found: C, 53.72%; H, 5.67%; N, 6.47%; F, 13.53%.
Complex 5: [(p-cymene)RuCl2] (100 mg, 163 mol) in dichloro-
methane (5.0 mL) and ligand L5 (190 mg, 326 mol) in dichloromethane
(5.0 mL). Ammonium hexafluorophosphate (263 mg, 1.17 mmol). Or-
ν,
cmꢀ 1): 3056 (w), 2965 (m), 2875 (w), 1593 (m), 1492 (m), 1456 (m),
1432 (m), 1392 (m), 1275 (m), 1125 (m), 841 (s), 774 (m), 687 (m), 558
(s). 1H NMR (300 MHz, CDCl3) (δ, ppm): 0.63 (s, 3H, CH3); 0.70 (s, 6H,
iPr-2CH3); 0.87 (s, 3H, CH3); 0.93 (s, 3H, CH3); 0.97 (s, 3H, CH3); 1.02
(s, 3H, CH3); 1.09 (s, 3H, CH3); 1.39–1.75 (m, 2H, CH2); 1.73–1.81 (m,
2H, CH2); 2.01–2.14 (m, 4H, 2CH2); 2.27–2.31 (m, 1H, iPr-CH); 2.62 (s,
3H, cymene CH3); 2.95–2.96 (d, J = 3.7 Hz, 1H, CH); 3.05–3.06 (d, J =
3.7 Hz, 1H, CH); 3.73 (s, 2H, cymene 2CH); 4.74–4.79 (d, 2H, cymene
2CH); 7.62–7.96 (m, 10H, 10CH). 13C{1H}NMR (75 MHz, CDCl3) (δ,
ppm): 10.19 (CH3); 11.89 (CH3); 19.03 (CH3); 19.29 (CH3); 20.18 (CH3);
20.29 (CH3) 21.52 (CH3); 21.77 (2CH3); 26.62 (CH2); 27.37 (CH2);
31.07 (CH); 33.40 (CH2); 33.51 (CH2); 47.80 (CH); 48.03 (CH); 54.35
(C); 55.03 (C); 62.37 (C); 64.94 (C); 78.18 (CH); 78.32 (CH); 84.41 (CH);
84.61 (CH); 100.70 (C); 105.31 (C); 126.28 (C); 126.55 (C); 129.63
(4CH); 130.76 (2CH); 130.92 (4CH); 137.31 (2C); 137.94 (C); 138.73
μ
μ
ange solid product (203 mg, 70%). M.P.: 298–300 ◦C (d). IR (KBr) (
ν,
cmꢀ 1): 3060 (w), 2963 (m), 2930 (w), 2872 (w), 1621 (w), 1594 (w),
1489 (m), 1455 (w), 1456 (w), 1391 (w), 1129 (m), 841 (s), 776 (m), 701
(m), 557 (s). 1H NMR (300 MHz, CDCl3) (δ, ppm): 0.58–2.46 (m, 72H,
18CH3, 8CH2, 2CH); 2.91 (s, 2H, 2CH); 3.01 (s, 2H, 2CH); 3.50–3.98 (d,
4H, cymene 4CH); 4.50–5.16 (d, 4H, cymene 4CH); 7.42–8.20 (m, 18H,
18CH). 13C{1H} NMR (75 MHz, CDCl3) (δ, ppm): Isomer A: 10.28 (CH3);
12.01 (CH3); 19.09 (CH3); 19.36 (CH3); 20.21 (CH3); 20.34 (CH3); 21.57
(CH3); 21.84 (2CH3); 26.69 (CH2); 27.35 (CH2); 31.15 (CH); 33.23
(CH2); 33.54 (CH2); 47.87 (CH); 48.12 (CH); 54.47 (C); 55.16 (C); 62.42
(C); 65.08 (C); 78.43 (2CH); 84.55 (2CH); 101.19 (C); 105.23 (C);
3